miscsubjectsAI governance
Evidence review

NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `nad-plus-trigeminal`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/nad-plus-trigeminal

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus-trigeminal/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/nad-plus-trigeminal/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/nad-plus-trigeminal/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/nad-plus-trigeminal/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why NAD+ might help you

  1. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • NAD+ → cellular energy

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 1
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 2

Quantified confidence (this ledger): 0.2 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Restoration of mitochondrial function alleviates trigeminal neuropathic pain in mice (source s2)

2025 mouse study using NR in CCI-IoN model; shows mitochondrial defects, NAD+ depletion, and NR benefits via Sirt1.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Double Whammy — Reddit, r/TrigeminalNeuralgia (source s3)

User mention of NAD+ in context of trigeminal neuralgia pain management discussion.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Trigeminal neuralgia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 2 sources · swipe →chain fb74fd23b52f · verify chain · provenance
Evidence ledger 3 · tier-ranked · API
humanlow confidence
No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related databases.
sources: s2
preclinicallow confidence
A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation improved mitochondrial function, activated Sirt1, downregulated pain and inflammatory genes, and reduced mechanical allodynia.
sources: s2
anecdotallow confidence
Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rather than direct pain resolution.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:39
NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models · 3 claims · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: NAD Plus for Trigeminal
Slug: nad-plus-trigeminal
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"nad-plus","name":"NAD+"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenera
it output
{
  "slug": "nad-plus-trigeminal",
  "title": "NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models",
  "body": "## What's breaking down\n\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\n\n## Why NAD+ might help you\n\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\n\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\n\n## What the evidence
89c98bda1f579ed7
Machine verification: /api/articles/nad-plus-trigeminal/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related database…"?
ask nad-plus-trigeminal claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation i…"?
ask nad-plus-trigeminal claim c1 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rathe…"?
ask nad-plus-trigeminal claim c3 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User mention of NAD+ in context of trigeminal neuralgia pain management discussion."
ask nad-plus-trigeminal source s3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models — and what would you need me to tell you first?
ask nad-plus-trigeminal condition gaps · paste includes §SELF
What good and bad outcomes are documented for NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models (studies vs anecdotes)?
ask nad-plus-trigeminal good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…